DocSym
β
Searchsearch
Search
(C95.2) Подострый лейкоз неуточненного клеточного типа
More details coming soon
100 430 in individuals diagnosis подострый лейкоз неуточненного клеточного типа confirmed
142 519 deaths with diagnosis подострый лейкоз неуточненного клеточного типа
142% mortality rate associated with the disease подострый лейкоз неуточненного клеточного типа
Diagnosis подострый лейкоз неуточненного клеточного типа is diagnosed Men are 8.48% more likely than Women
54 473
Men receive the diagnosis подострый лейкоз неуточненного клеточного типа
68 566 (125.9 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
45 957
Women receive the diagnosis подострый лейкоз неуточненного клеточного типа
73 953 (160.9 %)Died from this diagnosis.
Risk Group for the Disease подострый лейкоз неуточненного клеточного типа - Men aged 75-79 and Women aged 80-84
In Men diagnosis is most often set at age 0-95+
in in men, the disease manifests at any agein in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features подострый лейкоз неуточненного клеточного типа
Absence or low individual and public risk
Подострый лейкоз неуточненного клеточного типа - what does this mean
Acute leukaemia of unspecified cell type is a condition in which the bone marrow produces a large number of immature white blood cells, which can lead to a decrease in the production of healthy white blood cells, red blood cells and platelets. this can cause anemia, increased risk of infection and bleeding.
What happens during the disease - подострый лейкоз неуточненного клеточного типа
Podostryy leykoz neutochchennogo kletocnogo tipa is caused by the abnormal proliferation of white blood cells in the bone marrow. this leads to the decrease of healthy red blood cells, platelets and other healthy blood cells. the cause of the abnormal proliferation is unknown, but it is thought to be due to a combination of genetic and environmental factors. the symptoms of this disease include anemia, fatigue, easy bruising, and an increased risk for infection.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete blood count (CBC) to assess the number of white blood cells, red blood cells, and platelets
- Peripheral blood smear to evaluate the size, shape, and number of white blood cells
- Bone marrow aspiration and biopsy to examine the cells in the bone marrow and to confirm the diagnosis
- Cytogenetic analysis to identify any chromosomal abnormalities
- Flow cytometry to measure the amount and type of proteins on the surface of the cells
- Immunophenotyping to identify the different types of cells in the sample
- Molecular testing to identify the genetic mutations that may be associated with the disease
- Lumbar puncture to evaluate for the presence of abnormal cells in the cerebrospinal fluid
- Imaging studies such as X-rays, CT scans, and MRI scans to evaluate for any signs of tumor or organ involvement
Treatment and Medical Assistance
Main Goal: To reduce the severity of symptoms and improve overall health.
- Administering antibiotics to reduce infection and inflammation
- Provide supportive care, such as fluids and oxygen
- Prescribing medications to help reduce symptoms of the disease
- Performing blood transfusions to replenish red blood cells
- Conducting regular blood tests to monitor progress
- Providing nutritional support to help the body heal
- Conducting chemotherapy or radiation therapy if needed
- Performing bone marrow biopsies to diagnose and monitor the disease
16 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Подострый лейкоз неуточненного клеточного типа - Prevention
The best way to prevent acute leukaemia of unspecified cell type is to maintain a healthy lifestyle, avoid smoking and exposure to toxic chemicals, and get regular check-ups to detect any signs of the disease in its early stages. additionally, it is important to follow a balanced diet, get adequate sleep, and exercise regularly.